A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway

Shah, 2013, Hepatitis C Nosode: the preparation and homeopathic pathogenetic trial, Homeopathy, 102, 207, 10.1016/j.homp.2013.02.002 Shah, 2014, Scientific method of preparing homoeopathic nosodes, Indian J Res Homeopath, 8, 166, 10.4103/0974-7168.141740 Shah, 2015, HIV Nosode: The homeopathic pathogenetic trial, Forsch Komplementmed, 22, 156, 10.1159/000435845 Shah, 2016, A clinical evaluation of a Hepatitis C Nosode in the treatment of hepatitis C, J Altern Complement Med, 22, 197, 10.1089/acm.2014.0146 Mondal, 2016, Psorinum 6× triggers apoptosis signals in human lung cancer cells, J Integr Med, 14, 143, 10.1016/S2095-4964(16)60230-3 Alter, 2007, Epidemiology of hepatitis C virus infection, World J Gastroenterol, 13, 2436, 10.3748/wjg.v13.i17.2436 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Matassov, 2004, Measurement of apoptosis by DNA fragmentation, Methods Mol Biol, 282, 1 Khuda-Bukhsh, 1997, Potentized homeopathic drugs act through regulation of gene expression: a hypothesis to explain their mechanism and pathways of action in vivo, Complement Ther Med, 5, 43, 10.1016/S0965-2299(97)80090-8 Khuda-Bukhsh, 2014, Current trends in ultra-high dilution research with particular reference to gene regulatory hypothesis: review article, Nucleus, 57, 3, 10.1007/s13237-014-0105-0 Gerl, 2005, Apoptosis in the development and treatment of cancer, Carcinogenesis, 26, 263, 10.1093/carcin/bgh283 Kaufmann, 2003, Alterations in the apoptotic machinery and their potential role in anticancer drug resistance, Oncogene, 22, 7414, 10.1038/sj.onc.1206945 Krysko, 2008, Methods for distinguishing apoptotic from necrotic cells and measuring their clearance, Methods Enzymol, 442, 307, 10.1016/S0076-6879(08)01416-X Jackson, 2002, Sensing and repairing DNA double-strand breaks, Carcinogenesis, 23, 687, 10.1093/carcin/23.5.687 Abbotts, 2014, DNA repair in cancer: emerging targets for personalized therapy, Cancer Manag Res, 6, 77 Lakin, 1999, Regulation of p53 in response to DNA damage, Oncogene, 18, 7644, 10.1038/sj.onc.1203015 Christmann, 2013, Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation, Nucleic Acids Res, 41, 8403, 10.1093/nar/gkt635 Wang, 2002, Cellular roles of DNA topoisomerases: a molecular perspective, Nat Rev Mol Cell Biol, 3, 430, 10.1038/nrm831 Willmore, 2004, A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia, Blood, 103, 4659, 10.1182/blood-2003-07-2527 Thakur, 2011, Topoisomerrase II inhibitors in cancer treatment, Int J Pharm Sci Nanotechnol, 3, 1173 Trachootham, 2009, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nat Rev Drug Discov, 8, 579, 10.1038/nrd2803 Liu, 2015, Sanguinarine inhibits angiotensin II-induced apoptosis in H9c2 cardiac cells via restoring reactive oxygen species-mediated decreases in the mitochondrial membrane potential, Mol Med Rep, 12, 3400, 10.3892/mmr.2015.3841 Kim, 1994, Specific association of human telomerase activity with immortal cells and cancer, Science, 266, 2011, 10.1126/science.7605428 Shay, 2001, Telomerase and cancer, Hum Mol Genet, 10, 677, 10.1093/hmg/10.7.677 Hassan, 2014, Apoptosis and molecular targeting therapy in cancer, Biomed Res Int, 2014, 150845, 10.1155/2014/150845 Chikramane, 2012, Why extreme dilutions reach non-zero asymptotes: a nanoparticulate hypothesis based on froth flotation, Langmuir, 28, 15864, 10.1021/la303477s Rajendran, 2015, 170 Eskinazi, 1999, Homeopathy re-revisited: is homeopathy compatible with biomedical observations?, Arch Intern Med, 159, 1981, 10.1001/archinte.159.17.1981 Bell, 2013, Advances in integrative nanomedicine for improving infectious disease treatment in public health, Eur J Integr Med, 5, 126, 10.1016/j.eujim.2012.11.002 Bell, 2014, Integrative nanomedicine: treating cancer with nanoscale natural products, Glob Adv Health Med, 3, 36, 10.7453/gahmj.2013.009 Bell, 2013, Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions, Dose Response, 12, 202, 10.2203/dose-response.13-025.Bell